mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
-0.15 |
0.001 |
mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.14 |
0.002 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
-0.15 |
0.002 |
mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
AG-014699 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
AICAR |
GDSC1000 |
pan-cancer |
AAC |
0.095 |
0.003 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.005 |